AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

THOUSAND OAKS, Calif., Feb. 6, 2024 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year 2023 versus comparable periods in 2022. “2023 was another year of performance and progress for our company,” said Robert A. Bradway, chairman and…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks